Introduction
COVID-19 is often seen presenting with a myriad of signs and symptoms of multiorgan dysfunction including arterial dissection.
Method
Various theories have been proposed such as endothelial dysfunction triggered by hyper-inflammatory response that results in rupture of atherosclerotic plaque and subsequent dissection.
Result
However, the exact incidence is unknown and only case reports and case series have been published till date.
Conclusion
Here we carried out a systematic analysis of published case reports/series related to dissection of the aorta, coronary, cerebral, vertebral, cervical, renal, and splanchnic arteries.
Keywords: Aortic dissection, carotid dissection, vasculitis, coronavirus, SARS-COV-2, arterial dissections
1. INTRODUCTION
The novel virus SARS-COV-2 causing the current pandemic presents itself with a myriad of signs and symptoms involving multiorgan manifestations with a predominance of the respiratory system. There has been an exponential number of reports surfacing of multisite arterial dissections in COVID-19 patients without any antecedent causes, probably attributing to vasculopathy and/or vasculitis due to secondary causes [1]. It is proposed that SARS-COV-2-triggered inflammatory response exacerbates endothelial dysfunction, rupturing atherosclerotic plaque, thereby leading to hematoma and dissection [2].
Viral illnesses have been implicated in arterial dissection secondary to direct injury by viral replication or indirectly by autoimmune or proinflammatory cascades. Arterial dissection may be related to the intra-adventitial hematoma in a plaque dissecting the tunica by spreading longitudinally [3]. Compared to the non-influenza season, increased cases of aortic dissection and higher mortality rate in associated urgent surgeries are noted in the influenza season [4]. Viral infections with human immunodeficiency virus, hepatitis C, parvo virus B19, varicella zoster virus, and cytomegalovirus are associated with cerebral aneurysmal vasculopathy [5]. Interestingly, hepatitis B virus is responsible for around 36 to 50% of polyarteritis nodosa cases [6].
SARS-COV-2 binds to angiotensin-converting enzyme II receptors and disrupts endothelial function, resulting in endothelial inflammation (and thinning), and consequently, arterial dissection [1]. Massive cytokine storm, microthrombosis,and secondary endothelial injury are among the pathophysiological pathways implicating SARS-COV-2 in a hypercoagulable state [7]. High-dose corticosteroid therapy commonly used for the treatment of Covid-19 could also be a causative factor for spontaneous dissection in an already weakened arterial wall [8].
As the different afflictions of this virus manifest, it is pertinent that clinicians are aware of the various consequences while monitoring and providing optimal patient care. The mounting evidence of multiple cases and associated increased mortality and morbidity of Covid-19 patients with arterial dissection without any inciting factors is the basis of this review.
2. METHODOLOGY
2.1. Search Strategy and Data Extraction
We used the following search strategy: combinations of medical subject heading terms with the Boolean operators “And” or “Or”: “COVID 19”, “SARS -COV 2” “arterial dissection”/ “coronary artery dissection”/“cerebral artery dissection”/“cervical artery dissection”/ “vertebral artery dissection”. We searched the following databases: Medline, Cochrane Central, Google scholar, and Med Rx preprint server. The latest search date was 20th October, 2021. Additionally, we carried out a manual search for eligible references from the included studies. Two reviewers (BA and SDM) independently screened and extracted the necessary details. In case of any dispute, the third author (KS) was involved in the consultation, and a decision was taken. We included only case reports/series as there were no observational studies published at the time of preparing this manuscript. We used the Joanna Briggs Institute (JBI) Critical Appraisal tools for use in JBI Systematic Review Checklists for Case Reports for evaluating the quality of included reports [9]. This checklist has eight items, of which three items (numbers 5, 6, and 7) were not applicable for the present review as they were related to interventions, and so were excluded.
2.2. Population and Outcomes Of Interest
We included case reports/series that included any patient (child or adult) diagnosed with arterial dissection with COVID-19 infection. Arterial dissection at any location confirmed with an imaging modality, such as computed tomography (CT) angiography, magnetic resonance (MR) angiography, conventional angiography, or Doppler ultrasound imaging, was considered. Only those reports that included patients with laboratory-confirmed COVID-19 infection were included. Those reports with patients receiving corticosteroids, having concomitant history of trauma, pregnancy, arterial dissection-associated connective tissue disorders, and previous arterial dissections, were excluded. The following details were captured from each of the eligible reports: site of arterial dissection, associated symptoms, risk factors, COVID-19 severity (severe cases requiring mechanical ventilation), prognosis, and other relevant epidemiological and laboratory data.
2.3. Statistical Analysis
Descriptive statistics were used to represent the variables with numbers and percentages.
3. RESULTS
3.1. Included Studies
Our search hit 287 unique citations, of which 33 were finally included (Fig. 1). The JBI checklist revealed that almost all items were reported by each of the included studies (Table 1) [10-39].
Fig. (1).
Study flowchart.
Table 1.
JBI checklist evaluation of the included studies.
| JBI Checklist Item Numbers | 1 | 2 | 3 | 4 | 8 |
|---|---|---|---|---|---|
| Akgul et al. [10] | Y | Y | Y | Y | Y |
| Fesharaki et al. [11] | Y | U | Y | Y | Y |
| Mori et al. [12] | Y | Y | Y | Y | Y |
| Fukuhara et al. [13] | Y | Y | Y | Y | Y |
| Martens et al. [14] | Y | Y | Y | Y | Y |
| Tabaghi et al. [15] | Y | Y | Y | Y | Y |
| Farkash et al. [16] | Y | Y | Y | Y | Y |
| He H. et al. [17] | Y | U | Y | Y | Y |
| Taccherin et al. [18] | Y | Y | Y | Y | Y |
| Rossi et al. [19] | Y | Y | Y | Y | Y |
| Halasz G et al. [20] | Y | Y | Y | Y | Y |
| Albiero et al. [21] | Y | Y | Y | Y | Y |
| Gasso et al. [22] | Y | U | Y | Y | Y |
| Kumar et al. [23] | Y | U | Y | Y | Y |
| Kireev et al. [24] | Y | Y | Y | Y | Y |
| Cannata et al. [25] | Y | U | Y | Y | Y |
| Courand et al. [2] | Y | U | Y | Y | Y |
| Morassi et al. [26] | Y | Y | Y | Y | Y |
| Patel et al. [27] | Y | Y | Y | Y | Y |
| Papanikolaou et al. [28] | Y | Y | Y | Y | Y |
| Aparisi et al. [8] | Y | Y | Y | U | Y |
| Romiti S et al. [29] | Y | Y | Y | Y | Y |
| Dakay et al. [30] | Y | U | Y | Y | Y |
| Savic et al. [31] | Y | Y | Y | Y | Y |
| Hernandez-Fernandez et al. [32] | Y | U | Y | Y | Y |
| Jariwala et al. [33] | Y | Y | Y | Y | Y |
| Engin et al. [34] | Y | Y | Y | Y | Y |
| Dhaliwal et al. [35] | Y | U | Y | Y | Y |
| Voci et al. [36] | Y | Y | Y | Y | Y |
| Parmar et al. [37] | Y | Y | Y | Y | Y |
| Lopez Marco et al. [38] | U | N | U | Y | Y |
| Emren et al. [39] | Y | Y | Y | Y | Y |
JBI checklist items: 1. Were patient’s demographic characteristics clearly described? 2. Was the patient’s history clearly described and presented as a timeline? 3. Was the current clinical condition of the patient on presentation clearly described? 4. Were diagnostic tests or assessment methods and the results clearly described? 5. Does the case report provide takeaway lessons? Y-Yes; U-Unclear.
3.2. Demography and Clinical Symptomatology
42 patients were reported in the 33 included studies, with an age range of 13 to 81 years and a male preponderance (28/42, 66.6%). Nasopharyngeal RT-PCR technique was used to confirm Covid-19 in most cases (38/42, 90.4%). Most patients with mild COVID-19 infection (26/42, 61.9%) presented with arterial dissections. The majority of the patients (21/42,50%) were between 45 to 59 years, and there was one child (1/42, 0.02%). Most cases were reported from the USA (8/42, 19%) and Italy (6/42,14.2%). Common risk factors included hypertension (12/20,60%), diabetes mellitus (3/20, 15%), dyslipidemia (3/20, 15%), and smoking (3/20, 15%). No risk factors were identified in 20 patients (47.6%). Chest pain (19/42,45.2%), fever (14/42, 33.3%), and cough (14/42, 33.3%) were the commonly reported symptoms. The period between the onset of Covid-19-like symptoms and presentation to the hospital with symptoms/signs of arterial dissection ranged from 1 day to 8 weeks (n = 34). The average range of hospitalization was 3-22 days (n = 21).
Aortic dissections (22/42,52.3%), coronary artery (10/42, 23.8%), cerebral artery (3/42, 7.1%), vertebral artery (3/42, 7.1%), cervical artery (4/42, 9.5%), renal artery (1/42, 2.3%), and splanchnic artery dissections (1/42, 2.3%) were reported. Multiple (7/42, 16.6%) and bilateral (2/42, 4.7%) dissections were also reported. Type A aortic (17/42, 40.4%) and left anterior descending artery (7/42, 16.6%) were the commonly reported dissections.
3.3. Laboratory Findings
Coronary angiography (14/42, 33.3%) and CT angiogram (13/42, 30.9%) were the commonly used imaging modalities. Elevated C-reactive protein (CRP) and D-dimer levels were reported among 7 and 4 patients, respectively (n=13 reports), and ferritin was observed in 6 (n=9 report) patients. The details of the key characteristics of the individual reports for coronary artery dissections are mentioned in Table 2, those of cerebral/vertebral artery dissections are reported in Table 3, and of aortic dissections in Table 4.
Table 2.
Key characteristics of the reports on coronary artery dissection.
| Study ID | Age (Years) | Gender | Co-morbidities | Exact location of Dissection | Day of Identification | Imaging | Presenting Symptoms | CTD Workup | Elevated Inflammatory Markers | Outcomes | Covid-19 Severity | Duration of Hospital Stay (days) | Location |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Albiero et al. [21] | 70 | M | DM, HT, CAD, smoking | Proximal LAD | Day 2 | Coronary angiogram | Chest pain | NM | D-dimer = 736 ng/ml | Discharged with dual antiplatelet and anticoagulant drugs | Mild | 12 | Italy |
| Gasso et al. [22] | 39 | M | Nil | First obtuse marginal artery and proximal LAD | Day 1 | Coronary angiogram | Fever, chest pain, dyspnea, cough | Work up was negative | D-dimer = 322 ng/ml, CRP = 26 mg/L, Serum ferritin = 967 µg/L |
Discharged with dual antiplatelet drugs |
Severe | NM | Spain |
| Kumar et al. [23] | 48 | F | Migraine, dyslipidemia | LAD | - | Coronary angiogram | Chest pain | NM | NM | Discharged with aspirin | Mild | NM | USA |
| Kireev et al. [24] | 35 | M | Serpiginous choroiditis | Ramus intermedia and RCA | 15 days | Coronary angiogram | Chest pain, fever, cough, anosmia | NM | CRP = 12.5 mg/L, D-dimer = 234 ng/ml |
Discharged following stent | Mild | 13 | Russia |
| Cannata et al. [25] | 45 | F | Nil | LAD | 8 weeks prior | Coronary angiogram | Chest pain, anosmia | Work up was negative | NM | Discharged with dual antiplatelet drugs | Mild | NM | UK |
| Courand et al. [2] | 55 | M | PAD | Mid RCA | Day 1 | Coronary angiogram+ optical coherence tomogram | Fever, dyspnea, cough, chest pain | Work up was negative | NM | Discharge with aspirin |
Mild | NM | France |
| Morassi et al. [26] | 58 | M | Oligodendroglioma related epilepsy | Bilateral carotid artery | Day 1 | MR angiogram | Fever, headache, neck pain, cough | Work up was negative | CRP = 45.2 mg/L | Discharged with anticoagulant | Moderate | 22 | Italy |
| Papanikolaou et al. [28] | 51 | F | HT | LAD | Day 1 | Coronary angiogram | Fever, cough, dyspnea | Work up was negative | NM | Discharged with antiplatelet and anticoagulant | Mild | 18 | Saudi Arabia |
| Aparisi et al. [8] | 40 | M | NIL | Distal LAD | Day 1 | Coronary angiogram | Fever, dyspnea, cough | NM | D-dimer > 10000 ng/ml, CRP > 300 mg/L, Serum ferritin > 3000 µg/L |
Discharged with complete resolution along with aspirin | Severe | NM | Spain |
| Romiti S et al. [29] | 57 | F | Smoking, HT, dyslipidemia, hypothyroidism | First obtuse marginal LCX, LAD dissection | Day 1 | Coronary angiogram, Intravascular USG | Fever | NM | D-dimer = 383 ng/ml, CRP < 0.1 mg/L |
Discharged with anticoagulants | Mild | 21 | Italy |
| Emren et al. [39] | 50 | M | NIL | RCA | Day 7 | Coronary angiogram | Chest pain, cough | NM | NM | Discharged with antiplatelets | Mild | 2 | Turkey |
M - Male; F - Female; DM - Diabetes mellitus; HT - Hypertension; CAD - coronary artery disease; CTD - Connective tissue disorder; NM - Not mentioned; MR - Magnetic resonance; CTA - Computed tomography angiogram; DSA - Digital subtraction angiogram; USG - Ultrasonogram; LAD - left anterior descending artery; RCA - Right coronary artery; LCX - Left circumflex artery; PAD - Peripheral artery disease.
Table 3.
Key characteristics of the reports on cerebral/vertebral artery dissections.
| Age (in Years) | Study Type | Location | Gender | Location of Dissection | Comorbidities | Elevated Inflammatory Markers | COVID Severity | Presenting Symptoms | CTD Workup | Day of Symptom onset | Outcome | Treatment | Associated Neurological Conditions | Imaging | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dakay et al. [30] | 31 | Case series | USA | F | MCA and v2 segment vertebral artery dissection | Nil | Ferritin = 151 µg/L, CRP = 1.5 mg/L | Mild | NM | Negative | Day 1 | Discharged | Conservative | RCVS with SAH |
CTA |
| 57 | F | Cervical ICA | Nil | Dimer 7.79 ng/ml, Ferritin = 431 µg/L, CRP = 38 mg/L | Severe | NM | Negative | Day 1 | Unfavorable | Mechanical thrombectomy | Large vessel occlusion stroke | CTA | |||
| 81 | M | Cervical+supraclinoid ICA | Nil | Dimer >35 ng/ml, Ferritin = 772.8 µg/L, CRP = 17 mg/L | Severe | NM | Negative | Day 1 | Unfavorable | conservative | CTA | ||||
| Savic et al. [31] | 13 | Case report | Syria | F | M2 MCA | Nil | D-dimer 2032 ng/ml, CRP = 13 mg/L | Severe | Depressed consciousness+right side weakness | NM | Day 10 | Poor GCS | Frontotemporal craniectomy with hematoma evacuation | Left pseudo aneurysm +partial thrombosis | DSA, CTA |
| Hernandez-Fernandez et al. [32] | 62 | Case series | Spain | M | L vertebral artery V1+cerebellar infarction+basilar artery occlusion | HT | D-dimer 267 ng/ml, Ferritin = 918 µg/L | Mild | NM | Negative | Nil | Discharged | Mechanical thrombectomy | Vertebral-basilar infarct | CTA |
| 48 | Case series | Spain | M | Left Bulbar carotid Artery dissection |
Nil | D-dimer = 329 ng/ml, Ferritin = 361 µg/L | Mild | NM | Negative | Day 1 | Discharged | Conservative | Right parietal subacute infarction | CTA | |
| Patel et al. [27] | 39 | Case report | USA | M | V3-bilateral dissection | Nil | D-Dimer 224ng/ml,Ferritin 42ng/ml | Mild | Headache, neck pain | Negative | DAY 3 | Discharged | Conservative-medical | V3-bilateral-stenosis | CTA |
RCVS - Reversible cerebral vasoconstriction syndrome; SAH - Subarachnoid hemorrhage; DSA - Digital subtraction angiogram; CTA - Computed tomography angiogram; M - Male; F - Female; MCA - Middle cerebral artery; HT - Hypertension; ICA - Internal carotid artery
Table 4.
Key characteristics of the included reports on aortic dissections.
| Study Id | Study Report | Location | Gender | Age (in Years) | Covid-19 Severity | Affected Artery | Time from Initial Presentation | Outcome | Presenting Symptoms | Management | Comorbidities | Inflammatory Mark | Cardiac Enzymes | Imaging | Ctd Work Up | Np rt pcr | Duration of Hospital Stay (Days) | Treatment |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dhaliwal et al. [35] | Case report | NM | F | 76 | Mild | Type II aortic dissection | NM | discharge | Dyspnea, Chest pain |
surgical | HT, hyperlipidemia, COPD | NM | NM | NM | NM | + | 5 | Surgical |
| Engin M et al. [34] | Case report | NM | M | 62 | Mild | Type A aortic dissection | 30 | discharge | Chest pain | surgical | Chr atrial fibrillation, DM, lower extremity deep venous insufficiency | lactate dehydrogenase: 417 U/L, white blood cells: 11.26 103/µL; neutrophils: 10.04 103/µL; lymphocytes: 0.61 103/µ | NM | CTA | NM | + | 16 | Surgical |
| Fukuhara et al. [13] | Case series | NM | Male | 66 | NM | Type A aortic dissection | 21 | discharge | cough | Surgical repair | NM | NM | NM | NM | NM | + | 18 | Surgical |
| NM | Female | 40 | moderate | Type A aortic dissection | 42 | discharge | Fever, cough | Surgical repair | NM | NM | NM | NM | NM | + | 19 | Surgical | ||
| NM | male | 53 | severe | Type A aortic dissection | 1 | death | nil | Surgical repair | NM | NM | NM | NM | NM | + | 11 | surgical | ||
| Jariwala et al. [33] | Case report | India | male | 45 | moderate | Type B aortic dis | 3 | death | Fever, cough, dyspnea |
Surgical repair | nil | NM | NM | CTA | NM | + | 7 | surgical |
| Akgul et al. [10] | Case report | Turkey | female | 68 | mild | Type A | Day 1 | Discharged pod 14 | Chest pain, dyspnea |
Surgical repair | HT, DM |
CRP, ESR high |
NM | CTA | NM | NM | 14 | Surgical |
| Mori et al. [12] | Case series | USA | male | 54 | mild | Intra mural haematoma-aortic root + asc aorta | Day1 | discharged | Chest pain | Surgical repair | nil | - | NM | CTA | NM | + | 6 | Surgical |
| Fukuhara et al. [13] | Case report | USA | male | 56 | severe | Type A | Day 2 | death | Chest pain, abdominal pain |
Surgical repair | nil | - | NM | CTA | NM | + | 11 | Surgical |
| Martens et al. [14] | Case report | Belgium | male | 64 | Mild | Type A | Day 3 | discharged | Chest pain, cough, right leg ischaemia | Surgical repair | HT | CRP = 271 mg/dl, Ferritin = 610 ng/ml, lymphopenia |
NM | CTA, TTE | NM | + | 14 | Surgical |
| Tabaghi et al. [15] | Case report | Iran | Female | 47 | severe | Asc aorta+aortic root | Day 1 | death | Chest pain, diarrhea,cough |
nil | nil | - | NM | TTE | NM | + | 8 | |
| Farkash et al. [16] | Brief report | USA | Male | 53 | severe | Type A | Day 1 | death | - | Surgical repair | NIL | Lymphocytes-18000/µl | NM | CTA | NM | + | 12 | Surgical |
| He et al. [17] | Case Series | China | Male | 62 | mild | Type A | Day 1 | - | Chest pain | Surgical repair | NIL | NM | NM | CTA | NM | + | NM | Surgical |
| China | Female | 59 | mild | Type A | Day 1 | - | Fever, chest pain |
Surgical repair | hypertension | NM | NM | CTA | NM | + | NM | Surgical | ||
| Taccherinet al. [18] | Letter to editor | Italy | Male | 50 | Severe | De bakey 2 | 7 days early | death | Fever, syncope |
Surgical | NM | high | NM | CTA | NM | + | 10 | Surgical |
| Rossi et al. [19] | Case report | Italy | female | 64 | moderate | TypeB | Day 1 | discharge | Syncope,dyspnea,chest pain | surgical | - | NM | NM | CTA | NM | + | 14 | |
| Halasz G et al. [20] | Case series | Italy | male | 57 | mild | Type B | 12 | discharged | Chest pain, dyspnea | Heparin | nm | D-Dimer = 2383 ng/ml | NM | NM | NM | + | NM | NM |
| Lopez -Marco et al. [38] | Case series | UK | Male | 55 | Severe | Type A | NM | Discharged-unfavourable | Nm | Surgical | HT, IHD, smoking |
NM | NM | NM | NM | + | 45 | Surgical |
| UK | Male | 54 | Mild | Type A | NM | Discharged | NM | Surgical | HT | NM | NM | NM | NM | + | 15 | Surgical | ||
| UK | Male | 67 | Mild | Type A | NM | Discharged | NM | Surgical | HT | NM | NM | NM | NM | + | 9 | Surgical | ||
| UK | Male | 58 | Severe | Type A | NM | Died | Nm | Surgical | HT | NM | NM | NM | NM | + | 4 | Surgical |
Note: NM - Not mentioned; HT - Hypertension; COPD - Chronic obstructive pulmonary disease; IHD - Ischemic heart disease; CRP - C-reactive protein; ESR - Erythrocyte sedimentation rate.
3.4. Treatments Provided and Outcomes
Most patients with aortic dissection underwent surgical repair (18/21, 85.7%) and patients with coronary dissections were conservatively managed with anticoagulation and/or antiplatelets. 7 deaths (16.67%) were reported, and all of them were from aortic dissection. Seven patients (9/42, 21.4%) reported an unfavorable outcome, especially among patients with aortic dissection.
4. DISCUSSION
We carried out the present review reporting the clinical characteristics, risk factors, diagnostic and therapeutic management of patients with arterial dissections in confirmed Covid-19 infection. To the best of our knowledge, this is the first attempt to discern the possibility of association of arterial dissections in COVID-19 through a systematic approach. Most of the included reports were identified to have included key elements as per the quality assessment tool. This study enhances the understanding of the vascular manifestations of SARS-CoV-2, which is primarily considered a respiratory pathogen. Arterial dissections were commonly seen in the age group of 45 -59 years.
Spontaneous coronary artery dissection is more common in women; however, in the present review, more reports have been presented in males (probably related to a higher incidence of Covid-19 infection) [8]. Arterial dissection could occur at any time during index events, adding to the difficulty in diagnosis [8]. COVID-19 virus occurs in the lungs through the binding of spike proteins with the angiotensin-converting enzyme 2 (ACE 2) receptors that are also widely present in the endothelial cells [40]. COVID-19 virus, through feedback mechanism, activates the renin-angiotensin aldosterone system, leading to an imbalance between the vasodilatory and vasoconstrictor molecules in the blood vessels, thus leading to vasculitis [41]. Systemic vasculitis and vasculitis in the cerebral blood vessels have been observed to occur in the SARS-Cov-1 virus [42]. Systemic vasculitides can be grouped as small, medium, and large-sized, wherein large size refers to the involvement of the aorta and its branches [43]. In the present review, it was observed that almost all the cases with aortic dissection hardly had dissections of the other systemic blood vessels. We hypothesize that it may be due to the differences in the section of the artery that is affected in COVID-19 disease, like the differences in the vasculitis in Takayasu arteritis (arterial thickness is greater, and all the layers are involved in hyperplasia and neovascularization observed in tunica intima) and giant cell arteritis (more severe inflammation in the innermost part of tunica media) [43, 44]. Conservative management seems to appear as a safe strategy. The thrombolysis first approach advocated in Covid-19 patients with ST-elevation myocardial infarction could be risky in case of arterial dissection [9]. The prothrombotic state of Covid-19 raises serious concerns regarding anticoagulation and antiplatelet strategies [8].
The strength of the present review is that this is the only systematic compilation of reports related to this topic. However, there is a possibility that a large fraction of patients in this Covid-19 pandemic manifesting with diseases pathogenically not related to infection are infected. Low incidence, limitation in detection, and rapid mortality rate in certain groups may cause hindrance to causality confirmation. These cases may only be a blip on the radar while keeping in mind the serious issue of under-reporting in an exhaustive pandemic situation. This study is limited by a tiny sample size with insufficient data characteristics, scarce documentation on the follow-up period, and long-term sequelae. Larger epidemiological studies with rigorous design are needed to establish any possible association of arterial dissection among COVID-19 patients and anticoagulation strategies.
CONCLUSION
With the ever-evolving clinical manifestations of the current pandemic, a high degree of suspicion in diagnosing rare complications, like arterial dissection, is pertinent for timely management. Large-scale epidemiological studies will be needed to ascertain the causality of rapidly evolving COVID-19 and arterial dissection.
ACKNOWLEDGEMENTS
Declared none.
LIST OF ABBREVIATIONS
- JBI
Joanna Briggs Institute
- CRP
C-reactive Protein
CONSENT FOR PUBLICATION
Not applicable.
STANDARDS OF REPORTING
PRISMA guidelines were followed.
FUNDING
None.
CONFLICT OF INTEREST
The authors declare no conflict of interest, financial or otherwise.
SUPPLEMENTARY MATERIAL
PRISMA checklist is available as supplementary material on the publisher’s website along with the published article.
REFERENCES
- 1.Al-Mufti F., Becker C., Kamal H., et al. Acute cerebrovascular disorders and vasculopathies associated with significant mortality in SARS-CoV-2 patients admitted to the intensive care unit in the New York Epicenter. J. Stroke Cerebrovasc. Dis. 2021;30(2):105429. doi: 10.1016/j.jstrokecerebrovasdis.2020.105429. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Courand P.Y., Harbaoui B., Bonnet M., Lantelme P. Spontaneous coronary artery dissection in a patient with COVID-19. JACC Cardiovasc. Interv. 2020;13(12):e107–e108. doi: 10.1016/j.jcin.2020.04.006. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Jabbarli R., Reinhard M., Roelz R., et al. Intracerebral hematoma due to aneurysm rupture: Are there risk factors beyond aneurysm location? Neurosurgery. 2016;78(6):813–820. doi: 10.1227/NEU.0000000000001136. [DOI] [PubMed] [Google Scholar]
- 4.Ashur C., Conlon A., Eagle K., Bowman M. Influenza infection and aortic dissection: A commentary on the association between a viral syndrome and major cardiac events in the context of the current COVID-19 pandemic. J Allergy Infect Dis. 2020;1(1):10–15. [Google Scholar]
- 5.Bhayani N., Ranade P., Clark N.M., McGuinn M. Varicella-zoster virus and cerebral aneurysm: Case report and review of the literature. Clin. Infect. Dis. 2008;47(1):e1–e3. doi: 10.1086/588842. [DOI] [PubMed] [Google Scholar]
- 6.Cohen P., Guillevin L. Vascularites associées aux infections virales. Presse Med. 2004;33(19 Pt 2):1371–1384. doi: 10.1016/S0755-4982(04)98936-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Levi M. Pathophysiology of coagulopathy in hematological malignancies and in COVID-19. HemaSphere. 2021;5(6):e571. doi: 10.1097/HS9.0000000000000571. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Aparisi C, Ybarra-Falcón PE, García-Granja A, Uribarri H, Gutierrez IA. Santos.COVID-19 and spontaneous coronary artery dissection: Causality? Letters to the Editor. REC Interv Cardiol. 2021;3(2):134–43, 2017. [Google Scholar]
- 9.The Joanna Briggs Institute Critical Appraisal tools for use in JBI Systematic Reviews Checklist for Case Reports. Available at: https://jbi.global/sites/default/files/2019-05/JBI_Critical_Appraisal-Checklist_for_Case_Reports2017_0.pdf (Accessed on 22 Nov 2021)
- 10.Akgul A., Turkyilmaz S., Turkyilmaz G., Toz H. Acute aortic dissection surgery in a patient with COVID-19. Ann. Thorac. Surg. 2021;111(1):e1–e3. doi: 10.1016/j.athoracsur.2020.06.005. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Jafari Fesharaki M., Ansariaval Z., Alizadehasl A. Successful surgery in acute type A dissection in a patient with COVID-19. Indian Heart J. 2020;21(4):124–128. [Google Scholar]
- 12.Mori M., Geirsson A., Vallabhajosyula P., Assi R. Surgical management of thoracic aortic emergency with pre- and postoperative COVID-19 disease. J. Card. Surg. 2020;35(10):2832–2834. doi: 10.1111/jocs.14865. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Fukuhara S., Rosati C.M., El-Dalati S. Acute Type A aortic dissection during the COVID-19 outbreak. Ann. Thorac. Surg. 2020;110(5):e405–e407. doi: 10.1016/j.athoracsur.2020.04.008. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Martens T., Vande Weygaerde Y., Vermassen J., Malfait T. Acute Type A aortic dissection complicated by COVID-19 infection. Ann. Thorac. Surg. 2020;110(5):e421–e423. doi: 10.1016/j.athoracsur.2020.05.001. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Tabaghi S., Akbarzadeh M.A. Acute type A aortic dissection in a patient with COVID-19. Future Cardiol. 2020 doi: 10.2217/fca-2020-0103. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Farkash E.A., Wilson A.M., Jentzen J.M. Ultrastructural evidence for direct renal infection with SARS-CoV-2. J. Am. Soc. Nephrol. 2020;31(8):1683–1687. doi: 10.1681/ASN.2020040432. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.He H., Zhao S., Han L., et al. Anesthetic management of patients undergoing aortic dissection repair with suspected severe acute respiratory syndrome COVID-19 infection. J. Cardiothorac. Vasc. Anesth. 2020;34(6):1402–1405. doi: 10.1053/j.jvca.2020.03.021. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Taccheri T., Calabrese M., Arlotta G., Corsi F., Cavaliere F. Anesthetic management of patients undergoing aortic dissection repair with suspected severe acute respiratory syndrome coronavirus disease 2019 (COVID-19) infection. J. Cardiothorac. Vasc. Anesth. 2021;35(1):350–352. doi: 10.1053/j.jvca.2020.06.051. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Rossi G., Ferrari S.A., Sommaruga S., Muzzarelli L., Piconi S. An infection-oriented approach for thoracic endovascular aortic repair in a SARS-CoV-2 positive patient. A case report. Ann. Ital. Chir. 2020;91:273–276. [PubMed] [Google Scholar]
- 20.Halasz G., Di Spigno F., Piepoli M., et al. [Late occurrence of pulmonary embolsim in SARS-CoV-2 pneumonia: a case series] G. Ital. Cardiol. 2020;21(7):523–525. doi: 10.1714/3386.33638. [DOI] [PubMed] [Google Scholar]
- 21.Albiero R., Seresini G. Atherosclerotic Spontaneous Coronary Artery Dissection (A-SCAD) in a patient with COVID-19: Case report and possible mechanisms. Eur. Heart J. Case Rep. 2020;4(FI1):1–6. doi: 10.1093/ehjcr/ytaa133. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Fernandez Gasso L., Maneiro Melon N.M., Sarnago Cebada F., Solis J., Garcia Tejada J. Multivessel spontaneous coronary artery dissection presenting in a patient with severe acute SARS-CoV-2 respiratory infection. Eur. Heart J. 2020;41(32):3100–3101. doi: 10.1093/eurheartj/ehaa400. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Kumar K., Vogt J.C., Divanji P.H., Cigarroa J.E. Spontaneous coronary artery dissection of the left anterior descending artery in a patient with COVID-19 infection. Catheter. Cardiovasc. Interv. 2020:1–4. doi: 10.1002/ccd.28960. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Kireev K., Genkel V., Kuznetsova A., Sadykov R. Multivessel spontaneous coronary artery dissection in a patient after mild COVID-19: A case report. SAGE Open Med. Case Rep. 2020;8:X20975989. doi: 10.1177/2050313X20975989. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Cannata S., Birkinshaw A., Sado D., Dworakowski R., Pareek N. Spontaneous coronary artery dissection after COVID-19 infection presenting with ST segment elevation. Eur. Heart J. 2020;41(48):4602. doi: 10.1093/eurheartj/ehaa813. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26.Morassi M., Bigni B., Cobelli M., Giudice L., Bnà C., Vogrig A. Bilateral carotid artery dissection in a SARS-CoV-2 infected patient: causality or coincidence? J. Neurol. 2020;267(10):2812–2814. doi: 10.1007/s00415-020-09984-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.Patel P., Khandelwal P., Gupta G., Singla A. COVID-19 and cervical artery dissection- A causative association? J. Stroke Cerebrovasc. Dis. 2020;29(10):105047. doi: 10.1016/j.jstrokecerebrovasdis.2020.105047. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28.Papanikolaou J., Alharthy A., Platogiannis N., et al. Spontaneous coronary artery dissection in a patient with COVID-19. Coron. Artery Dis. 2021;32(4):354–355. doi: 10.1097/MCA.0000000000000991. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29.Romiti S., Totaro M., Laderchi A., Peruzzi M., Vinciguerra M., Greco E. Case report: Emergency CABG following failure of PTCA in a COVID-19 patient. Front. Cardiovasc. Med. 2021;7:620610. doi: 10.3389/fcvm.2020.620610. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30.Dakay K., Kaur G., Gulko E., et al. Reversible cerebral vasoconstriction syndrome and dissection in the setting of COVID-19 infection. J. Stroke Cerebrovasc. Dis. 2020;29(9):105011–1. doi: 10.1016/j.jstrokecerebrovasdis.2020.105011. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31.Savić D, Alsheikh TM, Alhaj AK, et al. Ruptured cerebral pseudoaneurysm in an adolescent as an early onset of COVID-19 infection: case report. Acta Neurochir. 2020;162(11):2725–9. doi: 10.1007/s00701-020-04510-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32.Hernández-Fernández F., Sandoval Valencia H., Barbella-Aponte R.A., et al. Cerebrovascular disease in patients with COVID-19: Neuroimaging, histological and clinical description. Brain. 2020;143(10):3089–3103. doi: 10.1093/brain/awaa239. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33.Jariwala P., Kamble R., Kale S.S., Mishra K.C., Jadhav K.P. A fatal association of COVID-19 and acute complicated Type-B aortic dissection: Interventional management in a difficult situation. IHJ Cardiovascular Case Reports. 2021;5(2):94–97. doi: 10.1016/j.ihjccr.2021.05.001. [DOI] [Google Scholar]
- 34.Engin M. Aydın U, Eskici H, Ata Y, Türk T. Type 1 Acute aortic dissection in the early period after COVID-19 infection. Cureus. 2021;13(3):e13751. doi: 10.7759/cureus.13751. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35.Dhaliwal K.K., Kon N.D. Stanford Type A Aortic Dissection in COVID-19 Patient - Do the Risks of Surgery Outweigh the Benefits? Wake Forest University School of Medicine. Available from: https://school.wakehealth.edu/About-the-School/Wake-Forest-Journal-of-Science-and-Medicine/Summer-2021/Stanford-Type-A-Aortic-Dissection-in-COVID-19-Patient (Accessed on May 31, 2022).
- 36.Voci D., Micieli E., Johner F.A., Kucher N., Barco S. Thrombosis and dissection of the abdominal arteries associated with infarcts of solid organs in a patient with COVID-19: A novel clinical entity. Hamostaseologie. 2021 doi: 10.1055/a-1476-7907. [DOI] [PubMed] [Google Scholar]
- 37.Parmar J., Patel T., Shah S., Kothari J., Dani S., Vyas S. Spontaneous renal artery dissection in COVID-19 pneumonia: Potential danger of cytokine storm. Case Rep. Crit. Care. 2021;2021:6696443. doi: 10.1155/2021/6696443. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 38.Lopez-Marco A., Rosser B., Harky A., et al. The fate of patients with acute aortic syndrome during the coronavirus (COVID-19) pandemic: A UK multicenter study. JTCVS Open. 2021;5:17–25. doi: 10.1016/j.xjon.2020.11.008. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 39.Yapan Emren Z., Emren V., Özdemir E., Karagöz U. Nazlı C. Spontaneous right coronary artery dissection in a patient with COVID-19 infection: A case report and review of the literature. Turk Kardiyol. Dern. Ars. 2021;49(4):334–338. doi: 10.5543/tkda.2021.34846. [DOI] [PubMed] [Google Scholar]
- 40.Divani A.A., Andalib S., Di Napoli M., et al. Coronavirus disease 2019 and stroke: Clinical manifestations and pathophysiological insights. J. Stroke Cerebrovasc. Dis. 2020;29(8):104941. doi: 10.1016/j.jstrokecerebrovasdis.2020.104941. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 41.Bourgonje A.R., Abdulle A.E., Timens W., et al. Angiotensin-Converting Enzyme 2 (ACE2), SARS-CoV-2 and the pathophysiology of coronavirus disease 2019 (COVID-19). J. Pathol. 2020;251(3):228–248. doi: 10.1002/path.5471. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 42.Ding Y., Wang H., Shen H., et al. The clinical pathology of Severe Acute Respiratory Syndrome (SARS): A report from China. J. Pathol. 2003;200(3):282–289. doi: 10.1002/path.1440. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 43.Saadoun D., Vautier M., Cacoub P. Medium and large vessel vasculitis. Circulation. 2021;143(3):267–282. doi: 10.1161/CIRCULATIONAHA.120.046657. [DOI] [PubMed] [Google Scholar]
- 44.Hotchi M. Pathological studies on Takayasu arteritis. Heart Vessels Suppl. 1992;7(S1):11–17. doi: 10.1007/BF01744538. [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Supplementary Materials
PRISMA checklist is available as supplementary material on the publisher’s website along with the published article.

